By Ed Devlin2026-10-30T14:21:00
Investors lost faith with Reckitt Benckiser’s recovery this week to send shares plummeting at the Durex and Strepsils owner.
The FTSE 100 group trimmed its growth forecasts for 2026 after being hit with unexpected manufacturing problems for its Lysol disinfectant brand in North America and weakness in the Chinese supplements business.
Already have an account? Sign in here
Already have an account? Sign in here